2Y1Z
Human alphaB Crystallin ACD R120G
Functional Information from PDB Data
site_id | AC1 |
Number of Residues | 3 |
Details | BINDING SITE FOR RESIDUE MRD A 1152 |
Chain | Residue |
A | SER135 |
A | SER136 |
B | MET137 |
site_id | AC2 |
Number of Residues | 3 |
Details | BINDING SITE FOR RESIDUE MPD A 1153 |
Chain | Residue |
A | GLU110 |
A | GLY112 |
A | PHE113 |
site_id | AC3 |
Number of Residues | 5 |
Details | BINDING SITE FOR RESIDUE MRD B 1151 |
Chain | Residue |
B | MET137 |
B | LEU143 |
A | MET137 |
A | SER138 |
B | SER135 |
site_id | AC4 |
Number of Residues | 4 |
Details | BINDING SITE FOR RESIDUE MRD B 1152 |
Chain | Residue |
A | ARG123 |
B | GLU110 |
B | HIS111 |
B | GLY112 |
Functional Information from SwissProt/UniProt
site_id | SWS_FT_FI1 |
Number of Residues | 4 |
Details | Binding site: {"evidences":[{"evidenceCode":"ECO:0000250"}]} |
Chain | Residue | Details |
site_id | SWS_FT_FI2 |
Number of Residues | 6 |
Details | Binding site: {"evidences":[{"source":"PubMed","id":"22890888","evidenceCode":"ECO:0000305"}]} |
Chain | Residue | Details |
site_id | SWS_FT_FI3 |
Number of Residues | 2 |
Details | Site: {"description":"Susceptible to oxidation"} |
Chain | Residue | Details |
site_id | SWS_FT_FI4 |
Number of Residues | 2 |
Details | Modified residue: {"description":"N6-acetyllysine; partial","evidences":[{"source":"PubMed","id":"11369851","evidenceCode":"ECO:0000269"},{"source":"PubMed","id":"22120592","evidenceCode":"ECO:0000269"}]} |
Chain | Residue | Details |